Emily Woodworth - 01 Mar 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP, Global Controller and CAO
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 01 Mar 2026
Net transactions value: -$28,588
Form type: 4
Filing time: 03 Mar 2026, 17:19:43 UTC
Previous filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Woodworth Emily	SVP, Global Controller and CAO	300 BOSTON SCIENTIFIC WAY, MARLBOROUGH	/s/ Susan Thompson, Attorney-in-Fact	03 Mar 2026	0002013518

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+838	+35%	$0.000000	3,231	01 Mar 2026	Direct	F1
transaction	BSX	Common Stock	Tax liability	$28,588	-372	-12%	$76.85	2,859	01 Mar 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-838	-33%	$0.000000	1,676	01 Mar 2026	Common Stock	838		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant.